MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4

References

• Stephanie L, Charlie , Ignace V. Epithelial ovarian cancer. Lancet. 2019;393(10177):1240–1253.
   Google Scholar
• Roett MA, Evans P. Ovarian cancer: an overview. Am Fam Physician. 2009;80(6):609–616.
   PubMed Web of Science ®Google Scholar
• Stewart C, Ralyea C, Lockwood S. Ovarian cancer: an integrated review. Semin Oncol Nurs. 2019;35(2):151–156.
   PubMed Web of Science ®Google Scholar
• Santaballa A, Barretina P, Casado A, et al. SEOM clinical guideline in ovarian cancer (2016). Clin Transl Oncol. 2016;18(12):1206–1212.
   PubMed Web of Science ®Google Scholar
• Leitao MM Jr. Management of epithelial ovarian cancer. Clin Adv Hematol Oncol. 2018;16:656–659.
   PubMed Web of Science ®Google Scholar
• Morgan RJ Jr., Alvarez RD, Armstrong DK, et al. Epithelial ovarian cancer. J Natl Compr Canc Netw. 2011;9(1):82–113.
   PubMed Web of Science ®Google Scholar
• Raitoharju E, Seppälä I, Oksala N, et al. Blood microRNA profile associates with the levels of serum lipids and metabolites associated with glucose metabolism and insulin resistance and pinpoints pathways underlying metabolic syndrome: the cardiovascular risk in young finns study. Mol Cell Endocrinol. 2014;391(1–2):41–49.
   PubMed Web of Science ®Google Scholar
• Plaisance-Bonstaff K, Renne R. Viral miRNAs. Methods Mol Biol. 2011;721:43–66.
   PubMedGoogle Scholar
• Cheng Y, Zhu H, Gao W. MicroRNA-330-3p represses the proliferation and invasion of laryngeal squamous cell carcinoma through downregulation of Tra2β-mediated Akt signaling. Onco Targets Ther. 2020;52:101574.
   Google Scholar
• Guan A, Wang H, Li X, et al. MiR-330-3p inhibits gastric cancer progression through targeting MSI1. Am J Transl Res. 2016;8(11):4802–4811.
   PubMed Web of Science ®Google Scholar
• Huang Y, Sun H, Ma X, et al. HLA-F-AS1/miR-330-3p/PFN1 axis promotes colorectal cancer progression. Life Sci. 2020;254:117180.
   PubMed Web of Science ®Google Scholar
• Jin Z, Jia B, Tan L, et al. miR-330-3p suppresses liver cancer cell migration by targeting MAP2K1. Oncol Lett. 2019;18(1):314–320.
   PubMed Web of Science ®Google Scholar
• Bähr C, Rohwer A, Stempka L, et al. DIK, a novel protein kinase that interacts with protein kinase Cdelta. Cloning, characterization, and gene analysis. J Biol Chem. 2000;275(46):36350–36357.
   PubMed Web of Science ®Google Scholar
• Chen L, Haider K, Ponda M, et al. Protein kinase C-associated kinase (PKK), a novel membrane-associated, ankyrin repeat-containing protein kinase. J Biol Chem. 2001;276(24):21737–21744.
   PubMed Web of Science ®Google Scholar
• Meylan E, Tschopp J. The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci. 2005;30(3):151–159.
   PubMed Web of Science ®Google Scholar
• Gong Y, Luo X, Yang J, et al. RIPK4 promoted the tumorigenicity of nasopharyngeal carcinoma cells. Biomed Pharmacother. 2018;108:1–6.
   PubMed Web of Science ®Google Scholar
• Qi Z-H, Xu H-X, Zhang S-R, et al. RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling. Int J Oncol. 2018;52(4):1105–1116.
   PubMed Web of Science ®Google Scholar
• Azizmohammadi S, Azizmohammadi S, Safari A, et al. High-level expression of RIPK4 and EZH2 contributes to lymph node metastasis and predicts favorable prognosis in patients with cervical cancer. Oncol Res. 2017;25(4):495–501.
   PubMed Web of Science ®Google Scholar
• Liu JY, Zeng QH, Cao PG, et al. RIPK4 promotes bladder urothelial carcinoma cell aggressiveness by upregulating VEGF-A through the NF-κB pathway. Br J Cancer. 2018;118(12):1617–1627.
   PubMed Web of Science ®Google Scholar
• Karagkouni D, Paraskevopoulou MD, Chatzopoulos S, et al. DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions. Nucleic Acids Res. 2018;46(D1):D239–d245.
   PubMed Web of Science ®Google Scholar
• Kameswaran V, Bramswig NC, McKenna LB, et al. Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets. Cell Metab. 2014;19(1):135–145.
   PubMed Web of Science ®Google Scholar
• Wang Z, Qu H, Gong W, et al. Up-regulation and tumor-promoting role of SPHK1 were attenuated by miR-330-3p in gastric cancer. J Cell Biochem. 2018;70:1164–1176.
   Google Scholar
• Yao Y, Zuo J, Wei Y. Targeting of TRX2 by miR-330-3p in melanoma inhibits proliferation. IUBMB Life. 2018;107:1020–1029.
   Google Scholar
• Zou L, Liu J, Lu H. Influence of protein kinase RIPK4 expression on the apoptosis and proliferation of chondrocytes in osteoarthritis. Mol Med Rep. 2018;17(2):3078–3084.
   PubMed Web of Science ®Google Scholar
• Busa T, Jeraiby M, Clémenson A, et al. Confirmation that RIPK4 mutations cause not only Bartsocas-Papas syndrome but also CHAND syndrome. Am J Med Genet Part A. 2017;173(11):3114–3117.
   PubMed Web of Science ®Google Scholar
• Hammond NL, Dixon J, Dixon MJ. Periderm: life-cycle and function during orofacial and epidermal development. Semin Cell Dev Biol. 2019;91:75–83.
   PubMed Web of Science ®Google Scholar
• Kousa YA, Moussa D, Schutte BC. IRF6 expression in basal epithelium partially rescues Irf6 knockout mice. Dev Dyn. 2017;246(9):670–681.
   PubMed Web of Science ®Google Scholar
• Lee P, Jiang S, Li Y, et al. Phosphorylation of Pkp1 by RIPK4 regulates epidermal differentiation and skin tumorigenesis. Embo J. 2017;36(13):1963–1980.
   PubMed Web of Science ®Google Scholar
• Huynh J, Scholz GM, Aw J, et al. Interferon regulatory factor 6 promotes keratinocyte differentiation in response to porphyromonas gingivalis. Embo J. 2017;85(5):e00858-16.
   Google Scholar
• Shamseldin HE, Khalifa O, Binamer YM, et al. KDF1, encoding keratinocyte differentiation factor 1, is mutated in a multigenerational family with ectodermal dysplasia. Hum Genet. 2017;136(1):99–105.
   PubMed Web of Science ®Google Scholar
• Liu DQ, Li FF, Zhang JB, et al. Increased RIPK4 expression is associated with progression and poor prognosis in cervical squamous cell carcinoma patients. Sci Rep. 2015;5(1):11955.
   PubMed Web of Science ®Google Scholar
• Kage H, Borok Z. EMT and interstitial lung disease: a mysterious relationship. Curr Opin Pulm Med. 2012;18(5):517–523.
   PubMed Web of Science ®Google Scholar
• Huang X, McGann JC, Liu BY, et al. Phosphorylation of dishevelled by protein kinase RIPK4 regulates Wnt signaling. Science (New York, NY). 2013;339(6126):1441–1445.
   Google Scholar
• Dong P, Fu H, Chen L, et al. PCNP promotes ovarian cancer progression by accelerating β-catenin nuclear accumulation and triggering EMT transition. J Cell Mol Med. 2020;24(14):8221–8235.
   Web of Science ®Google Scholar
• McMellen A, Woodruff ER, Corr BR, et al. Wnt signaling in gynecologic malignancies. Int J Mol Sci. 2020;21(12):21.
   Web of Science ®Google Scholar
• Harrington BS, Annunziata CM. NF-κB signaling in ovarian cancer. Cancers (Basel). 2019;11(8):11.
   Web of Science ®Google Scholar